Our drug screening device is currently in development.
Sign up to our newsletter for regular updates.
We have scaled our Cambridge-based manufacturing capacity ten-fold over the last year in readiness for the commercialisation of our unique, portable, fingerprint-based drug screening system.
We were delighted to welcome Mousumi Bakshi from BBC Look East to our HQ today. Mousumi was reporting on our recent £3m investment funding boost.
Intelligent Fingerprinting has secured a further £3 million of funding from an expanded group of private US and UK investors. The investment will support early commercialisation of our first drug screening panel, and include manufacturing scale-up and validation of the first products made at our dedicated facility in Cambridge.
Intelligent Fingerprinting's Dr Paul Yates is in Venice to present Intelligent Fingerprinting's 'blueprint for 21st century drug screening' at the 12th Global Addiction Conference this weekend.
Our CEO, Jerry Walker, has been interviewed by Cambridge TV's Business Focus programme. On the show Jerry reveals details of our innovative fingerprint-based drug test which is currently in the final stages of development at Intelligent Fingerprinting.
We are pleased to announce the investment of a further £2.5m in Intelligent Fingerprinting by private UK and US investors. The funding will provide working capital to complete the development of our first products and to begin manufacturing at our new custom-designed premises in Cambridge.
We're celebrating the opening of our new global HQ at Evolution Business Park in Cambridge. The new premises include custom-designed commercial, R&D and manufacturing facilities and will provide the ideal base for developing our innovative fingerprint-based diagnostics products fully in the UK.
Discussions are underway to extend the pilot of a new mobile drug screening technology pioneered by Intelligent Fingerprinting to nine coroners’ areas following presentation of evaluation data to the recent Coroner’s Society of England and Wales Annual Conference.
Philip Hand, a drug industry veteran with more than 20 years’ experience in medical diagnostics, has been appointed Chairman at Intelligent Fingerprinting.
We're proud to announce that Intelligent Fingerprinting has achieved the international standard for medical device quality management, ISO 13485.
We're delighted to have been selected to exhibit our fingerprint drug screening technology at Innovate UK 2014, the UK's leading event for businesses to meet other businesses, Government and academia with the aim of making innovation and trade happen.
Philip Hand has joined our Board as a non-executive director. Phil is a veteran of the drug screening industry and is known for his success in bringing diagnostic screening products to market.
Intelligent Fingerprinting has secured £2.98m in new funding from private UK and US-based backers. The investment will be used to scale up production capabilities and finalise development of the company's handheld fingerprint-based drug screening device.
We’re pleased to announce that Michael Chard has joined us as Head of Operations. We have also recruited two more Senior R&D Scientists and two Production Scientists to strengthen the team developing our revolutionary fingerprint drug screening device.
Intelligent Fingerprinting has secured £750,000 in funding from a consortium of private US-based investors. The funding boost will be used to support the final stages in the development of the company’s non-invasive drug screening technology.
Come and meet us later this year at the Forensic Medicine event taking place at Birmingham's NEC on 16 and 17 September.
Our fingerprint drug screening technique is to be trialled in an Anglo-Finnish opioid drug rehabilitation project, thanks to 1 million euro grant from Eurostars.
We're proud to announce that Intelligent Fingerprinting has once again been named a 'Future 50' company by the Eastern Daily Press (EDP), one of the UK's largest regional newspapers.
Intelligent Fingerprinting was one of a small selection of UK organisations invited to present at the Applications of Forensic Science R&D Technology Showcase in London this week.
Intelligent Fingerprinting has been invited to present its revolutionary fingerprint-based drug screening technology to the Home Office at a forensic technology event in London on 8 October.
Intelligent Fingerprinting has secured access to a multi-billion dollar global market for its revolutionary handheld drug-testing device, with the award of its first US patent.
Intelligent Fingerprinting has been awarded a share of a £39 million healthcare grant, announced by minister for science and universities David Willetts.
Intelligent Fingerprinting has been named the ‘One to Watch’ business in 2012 by the Eastern Daily Press, one of the UK’s largest regional daily newspapers. The One to Watch category recognises an emerging business which shows the promise to become a success story of tomorrow.
Intelligent Fingerprinting has announced an agreement with Dallas-based Smart Start Inc granting them exclusive North American marketing and distribution rights for Intelligent Fingerprinting’s drugs of abuse detection products.
Intelligent Fingerprinting has raised £2m in funding from a consortium of private US-based investors. The investment will allow our unique product, which detects illegal drugs from the sweat in fingerprints, to be marketed worldwide.
Intelligent Fingerprinting has been named as one of the EDP's Future 50 companies 2011.
The world’s first prototype of a hand-held fingerprint drug testing device has been created by UK technology company Intelligent Fingerprinting. The unique device detects drugs and other substances from the sweat contained in fingerprints and will enable mobile testing with rapid results.
Intelligent Fingerprinting has appointed Dr Paul Yates as Business Development Manager.
Intelligent Fingerprinting has announced today that it has secured £300,000 of investment from Synergis Technologies together with the Iceni Seedcorn fund.
Intelligent Fingerprinting, in conjunction with the University of East Anglia, has been shortlisted for the Times Higher Educational Awards 2010 in the "Outstanding Contribution to Innovation and Technology" category.
Intelligent Fingerprinting has completed its first round seed funding through the ICENI challenge fund. The funds will be released in two tranches over 2 years against pre-agreed milestones linked to use of its high definition, high sensitivity fingerprinting technology for simultaneous detection of identity and chemical metabolites secreted through the skin.